Elbit Medical Technologies Ltd
ELBDF
$0.05
-$0.01-16.67%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 5.49% | 5.49% | -14.29% | -14.29% | -2.67% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.49% | 5.49% | -14.29% | -14.29% | -2.67% |
| Operating Income | -5.49% | -5.49% | -2,566.67% | -2,566.67% | 2.67% |
| Income Before Tax | -126.38% | -126.38% | 102.56% | 102.56% | 117.23% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -126.38% | -126.38% | 102.56% | 102.56% | 117.23% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -126.38% | -126.38% | 102.56% | 102.56% | 117.23% |
| EBIT | -5.49% | -5.49% | -2,566.67% | -2,566.67% | 2.67% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 102.80% | 102.80% | 102.80% | 102.80% | -424.00% |
| Normalized Basic EPS | -- | -- | 0.00% | 0.00% | -- |
| EPS Diluted | 102.80% | 102.80% | 102.80% | 102.80% | -424.00% |
| Normalized Diluted EPS | -- | -- | 0.00% | 0.00% | -- |
| Average Basic Shares Outstanding | -- | -- | -6.57% | -6.57% | -- |
| Average Diluted Shares Outstanding | -6.57% | -6.57% | -6.57% | -6.57% | 15.14% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |